21 research outputs found

    Solar-like oscillations in the G2 subgiant beta Hydri from dual-site observations

    Full text link
    We have observed oscillations in the nearby G2 subgiant star beta Hyi using high-precision velocity observations obtained over more than a week with the HARPS and UCLES spectrographs. The oscillation frequencies show a regular comb structure, as expected for solar-like oscillations, but with several l=1 modes being strongly affected by avoided crossings. The data, combined with those we obtained five years earlier, allow us to identify 28 oscillation modes. By scaling the large frequency separation from the Sun, we measure the mean density of beta Hyi to an accuracy of 0.6%. The amplitudes of the oscillations are about 2.5 times solar and the mode lifetime is 2.3 d. A detailed comparison of the mixed l=1 modes with theoretical models should allow a precise estimate of the age of the star.Comment: 13 pages, 14 figures, accepted by ApJ. Fixed minor typo (ref to Fig 14

    The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Get PDF
    Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

    A search for solar-like oscillations in K giants in the globular cluster M 4

    No full text
    International audienceContext: To expand the range in the colour-magnitude diagram where asteroseismology can be applied, we organized a photometry campaign to find evidence for solar-like oscillations in giant stars in the globular cluster M 4. Aims: The aim was to detect the comb-like p-mode structure characteristic for solar-like oscillations in the amplitude spectra. The 24 main target stars are in the region of the bump stars and have luminosities in the range 50-140 {L}&sun;. Methods: We collected 6160 CCD frames and light curves for about 14 000 stars were extracted. The frames consist of exposures in the Johnson B, V and R bands and were obtained at three different telescopes. Three different software packages were applied to obtain the lowest possible photometric noise level. The resulting light curves have been analysed for signatures of oscillations using a variety of methods. Results: We obtain high quality light curves for the K giants, but no clear oscillation signal is detected. This is a surprise as the noise levels achieved in the amplitude spectra should permit oscillations to be seen at the levels predicted by extrapolating from stars at lower luminosities. In particular, when we search for the signature of oscillations in a large number of stars we might expect to see common features in the power spectra, but even here we fall short of having clear evidence of oscillations. Conclusions: High precision differential photometry is possible even in very crowded regions like the core of M 4. Solar-like oscillations are probably present in K giants, but the amplitudes are lower than classical scaling laws predict. The reasons may be that the lifetime of the modes are short or the driving mechanism is relatively inefficient in giant stars
    corecore